N/A N=100 Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone
Breast Cancer
Primary: Compare Per Subject Area Under Curve (AUC): FFDM Only vs DBT Plus FFDM — 100; 100 Probability
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=89 The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Tardive Dyskinesia (TD)
Primary: Participants With Withdrawal-Emergent Adverse Events — 9; 13 Participants
N/A N=14 Effects of Exercise Training on Fluid Instability in Heart Failure Patients
Heart Failure
Primary: Bioelectrical Impedance Change — 47.52; 47.1; 41.27; 46.8 Percentage of Extra Cellular Fluid
Phase 3 N=213 Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
Venous Thromboembolism · Secondary Prevention
Primary: Event-free Probability of Recurrence of Venous Thromboembolism (VTE) at 6 and 12 Months — 1.000; 1.000; 0.979; 1.000 Probability
Phase 2 N=156 Dose-Ranging Study of the Bimatoprost Ocular Insert
Primary Open-Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Intraocular Pressure (IOP) at Week 8 — -4.68; -3.68; -4.56; -3.62 mm Hg
N/A N=9 A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302
Phenylketonuria
Primary: Change From Baseline in Rapid Visual Processing (RVP) Mean Response Latency (CANTAB Task) — -24.23; 18.03 Millisec
N/A N=84 Single Session of tACS in a Depressive Episode
Depression · Major Depressive Disorder · Premenstrual Dysphoric Disorder
Primary: Change in Alpha Frequency Electrical Activity in Left Frontal Cortex From Stimulation — -0.005; 0.008; 0.004; 0.007 microvolts — p=0.0852
Phase 2 N=66 A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
Pneumococcal Infections
Primary: Stage 1: Percentage of Participants With Local Reactions Within 14 Days After Vaccination — 2.9; 12.5; 2.9; 6.3 percentage of participants
Phase 2 N=92 Study of the Medication Prazosin for Alcohol Dependence
Alcoholism
Primary: Alcohol Consumption — 71.8; 66.5; 11.4; 22.6 percentage of days heavy drinking
Phase 4 N=26 Beta Blockade in in Traumatic Brain Injury
Brain Injuries, Traumatic
Primary: Mortality — 7.7; 33.3 percentage of participants
N/A N=110 Cognitive Rehabilitation for PD
Parkinson's Disease
Primary: Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score — 0.22; 0.42 score on a scale — p=0.6662
N/A N=27 Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)
Transposition of the Great Vessels · Hypoplastic Left Heart Syndrome · Oxygen Consumption Based Assessment of Hemodynamics
Primary: Oxygen Consumption — 72; 102 mL oxygen/min/m^2
N/A N=149 To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function
Dry Skin · Skin Care
Primary: Change From Baseline in Trans-epidermal Water Loss (TEWL) Following Application of Test Regimen on Face (Area 1 Compared to Area 2) at Day 29 — -5.077; -4.946; -3.692…
N/A N=22 Sham CPAP vs. Straight CPAP for Chronic Cough
Chronic Cough · OSA
Primary: Change in Leicester Cough Questionnaire Score — 6.61; 2.07 score on a scale
N/A N=56 Insomnia Treatment and Problems (the iTAP Study)
Insomnia · Alcohol; Harmful Use
Primary: Insomnia Severity — 6.86; 10.84; 6.58; 9.32 units on scale, Insomnia Severity Index